v3.23.2

Equity (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2023 | Jun. 30, 2022
Stockholders' Equity Note [Abstract] |  |
Schedule of fair value of each equity-based award is estimated period |
Stock price volatility |  | 175%
Expected term |  | 5 years
Discount rate |  | 3.38%
Expected dividends |  | 0%
Stock price volatility |  | 190%
Expected term |  | 1 year
Risk-free interest rate |  | 3.21%
Expected dividends |  | 0%
Stock price volatility | 190%
Expected term | 1 year
Risk-free interest rate | 3.21%
Expected dividends | 0%
Schedule of warrant status |
|  | Warrants |  | Weighted Average Exercise Price
| Outstanding, June 30, 2022 | 600,000 |  | $0.01
| Granted | 1,400,000 |  | 0.01
| Granted | 2,100,000 |  | 0.10
| Forfeited | - |  | -
| Outstanding, March 31, 2023 | 4,100,000 |  | $0.09
| Exercisable, end of period | $3,100,000 |  | -
| Warrants | Weighted Average Exercise Price
Outstanding, beginning of year | - | $ -
Granted | 600,000 | 0.50
Forfeited | - | -
Outstanding, end of year | 600,000 | $ 0.50
Exercisable, end of year | 600,000 |
Schedule of warrants outstanding |
|  | Exercise |  | Number |  | Number |  | Weighted Average |  | Intrinsic
Warrants |  | Price |  | Exercisable |  | Outstanding |  | Remaining Life |  | Value
600,000 |  | $ 0.01 |  | 600,000 |  | 600,000 |  | 4.5 years |  | $ -
1,000,000 |  | $ 0.01 |  | - |  | 1,000,000 |  | 4.7 years |  | $ 150,000
400,000 |  | $ 0.01 |  | 400,000 |  | 400,000 |  | 4.5 years |  | $ 243,250
2,100,000 |  | $ 0.10 |  | 2,100,000 |  | 2,100,000 |  | 4.9 years |  | $ 99,184
2,100,000 |  | $ 0.10 |  | - |  | - |  | 5 years |  | $ -
Warrants | Exercise price | Number Exercisable | Number Outstanding | Weighted Average Remaining Life | Intrinsic Value
600,000 | $ 0.50 | 600,000 | 600,000 | 5 years | Amount is negligible

X
- Definition Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration